Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

198.79 +2.86 (+1.46%)
Streaming Delayed Price Updated: 10:12 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,184,339
Open 196.96
Bid (Size) 198.75 (100)
Ask (Size) 198.83 (100)
Prev. Close 195.93
Today's Range 195.90 - 198.95
52wk Range 140.68 - 197.18
Shares Outstanding 2,628,679,824
Dividend Yield 2.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Labor Market Jitters Send Shockwaves Through Wall Street: Investors Brace for Economic Slowdown Amidst Delayed Data
The financial markets are grappling with a turbulent period as recent labor market reports, particularly those reflecting October 2025 data, paint a picture of a weakening economy. With official... 
Via MarketMinute
Topics Bonds Economy Stocks
News headline image
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗
Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics. 
Via Investor's Business Daily

Performance

YTD
+38.0%
+38.0%
1 Month
+2.9%
+2.9%
3 Month
+12.8%
+12.8%
6 Month
+30.4%
+30.4%
1 Year
+28.4%
+28.4%

More News

Read More
News headline image
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
From Johnson & Johnson
Via Business Wire
News headline image
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Federal Reserve's Hawkish Stance Crushes Gold and Silver, Dashing December Rate Cut Hopes
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Global Markets Shaken by AI Concerns and Rate Cut Doubts, Wall Street Stages Volatile Recovery
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy ↗
Via Benzinga
News headline image
Market Rally Stumbles: Investors Grapple with Shifting Sentiments Amidst Economic Headwinds
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Stock Market Plunges: Dow Drops 500 Points Amid Broad Sell-Off and Escalating Investor Fear
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Bristol Myers Slumps After Its Heart Condition Study Gets The Boot ↗
Via Investor's Business Daily
News headline image
BMY Stock Slumps 5% After It Scraps Heart Drug Study ↗
Via Stocktwits
News headline image
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Post-Shutdown Jitters: Markets Reel as Government Reopens
Via MarketMinute
Topics Bonds Economy Government
News headline image
A Look Into Johnson & Johnson Inc's Price Over Earnings ↗
Via Benzinga
News headline image
Decoding Johnson & Johnson's Options Activity: What's the Big Picture? ↗
Via Benzinga
News headline image
Market Jitters Persist as Wall Street Opens Lower Amidst Economic Headwinds and Geopolitical Tensions
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Market Sentiment Pivots: From Momentum to Caution in Late 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens
Via MarketMinute
Topics Credit Cards Economy World Trade
News headline image
Dow's Resilient Dance: Navigating Pullback Worries Amidst Tech Valuation Scrutiny
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon ↗
Via The Motley Fool
News headline image
2 Strong Healthcare Stock Picks for Dividend Investors ↗
Via The Motley Fool
Topics Economy
News headline image
Economic Blind Spot: White House Announces October CPI Data May Never See Light Amidst Shutdown
Via MarketMinute
Topics Bonds Economy
News headline image
The Shadow of Uncertainty: How a Government Shutdown Once Jeopardized Crucial Jobs Data
Via MarketMinute
Topics Credit Cards Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 198.79
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 11/17/25 10:12 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 522.56B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 523B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.